Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wednesday, July 11, 2012 - 12:12pm
tags:
Xenon, Virobay, Tolero Pharmaceuticals, Threshold Pharmaceuticals, Novartis, Merck KGaA, Merck, MannKind, licensing, Janssen, Isis Pharmaceuticals, Ironwood, Inhibrx Thrombogenics, GSK, Genmab, Genentech, Galapagos, Forma Therapeutics, Endocyte, Endo, Enanta, Celgene, Bristol-Myers Squibb, Boehringer Ingelheim, Bionomics, Biogen Idec, BioDelivery Sciences, AstraZeneca, Angiochem, AC Immune, Abbott Laboratories, LEO Pharma
Lilly could net $1.5B-plus from Cymbalta extension
Fierce Pharma
Wednesday, July 11, 2012 - 12:08pm
tags:
Eli Lilly, Cymbalta, antidepressants
The Butterfly Effect Of The Affordable Care Act
Seeking Alpha
Wednesday, July 11, 2012 - 12:05pm
tags:
Affordable Care Act, healthcare reform, Abbott Laboratories, Merck, Pfizer, Unitedhealth Group, Wellpoint
Pfizer Is Worth $25 Despite Lawsuits And Lipitor Patent Expiry
Forbes
Wednesday, July 11, 2012 - 12:04pm
tags:
Lipitor, Pfizer, patents
Closer Look: Furiex's Big Bounce
Seeking Alpha
Wednesday, July 11, 2012 - 12:04pm
tags:
Furiex Pharmaceuticals, JNJ, Takeda, Eli Lilly
Eli Lilly treatment for acute schizophrenia fails in late-stage study comparing it to placebo
Yahoo/AP
Wednesday, July 11, 2012 - 11:42am
tags:
Eli Lilly, schizophrenia, antipsychotics, pomaglumetad methionil
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test
Bloomberg
Wednesday, July 11, 2012 - 10:19am
tags:
GSK, HIV, AIDS, Shionogi, Gilead, Atripla, Dolutegravir
Eisai's Halavan misses endpoints in Phase III trial
Pharma Times, UK
Wednesday, July 11, 2012 - 10:06am
tags:
Eisai, Halavan, Xeloda, breast cancer
J&J-Pfizer Drug Long Shot Against Alzheimer’s
Bloomberg Businessweek
Wednesday, July 11, 2012 - 9:48am
tags:
Alzheimer's disease, Pfizer, JNJ, bapineuzumab
Why Hedge Funds Prefer Vivus Over Arena
Seeking Alpha
Wednesday, July 11, 2012 - 9:46am
tags:
Vivus, Arena, Qnexa, Belviq, GSK, Orexigen
Orexigen's Light Study for Contrave enrolling faster than projected
Yahoo/Fly on the Wall
Wednesday, July 11, 2012 - 9:43am
tags:
Orexigen, Contrave
June Meeting Between Amarin and FDA May Have Decided Fate of Fish-Oil Pill
TheStreet.com
Wednesday, July 11, 2012 - 9:29am
tags:
FDA, Amarin, AMR101
Allergan estimates lowered on CVS/Caremark exclusion, says Leerink
The Fly on the Wall
Tuesday, July 10, 2012 - 1:05pm
tags:
Allergan, CVS, Caremark
Merck Hid Evidence Of Vioxx Harm: Study
Pharmalot
Tuesday, July 10, 2012 - 12:11pm
tags:
Vioxx, Merck
Athersys receives orphan drug designation for MultiStem
The Fly on the Wall
Tuesday, July 10, 2012 - 12:11pm
tags:
orphan drugs, MultiStem, Athersys
Cubist Sues Hospira Over Cubicin Bacteria Medicine Patent
Bloomberg
Tuesday, July 10, 2012 - 11:47am
tags:
Cubicin, Cubist, Hospira, MRSA
U.S. Patients Get Access To More Cancer Drugs, But Pay For The Privilege
Forbes
Tuesday, July 10, 2012 - 11:34am
tags:
cancer
Exclusive: Icahn offered to settle with Forest before battle
Reuters
Tuesday, July 10, 2012 - 11:18am
tags:
Carl Icahn, Forest Labs
Onyx Pharma Must Start Delivering Profits
TheStreet.com
Tuesday, July 10, 2012 - 11:17am
tags:
ONYX Pharmaceuticals
CEO of Indian drugmaker Ranbaxy Laboratories planning expansion in US and emerging markets
Yahoo/AP
Tuesday, July 10, 2012 - 11:16am
tags:
India, emerging markets, Ranbaxy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.